Benzodiazepines

Encyclopedia of Stress

Volumn , Issue , 2007, Pages 310-316

  Bermak, J ^a   Johnstone, T ^b   Gee, K ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882873847     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012373947-6.00422-0     Document Type: Chapter

References (15)

1. Cates M.E., Bishop M.H., Davis L.L., et al. Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder. Annals of Pharmacotherapy 2004, 38:1395-1399.
2. Davidson J.R. Use of benzodiazepines in social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder. Journal of Clinical Psychiatry 2004, 65(supplement 5):29-33.
3. Furukawa T.A., Streiner D.L., Young L.T. Antidepressant and benzodiazepine for major depression. The Cochrane Library (Issue 1) 2002, Wiley, Chichester, (Cochrane Review).
4. Kindt M., Engelhard I.M. Trauma processing and the development of posttraumatic stress disorder. Journal of Behavior Therapy and Experimental Psychiatry 2005, 36:69-76.
5. Korpi E.R., Sinkkonen S.T. GABA(A) receptor subtypes as targets for neuropsychiatric drug development. Pharmacology & Therapeutics 2006, 109:12-32.
6. Mancuso C.E., Tanzi M.G., Gabay M. Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy 2004, 24:1177-1185.
7. Möhler H., Okada T. Benzodiazepine receptor: demonstration in the central nervous system. Science 1977, 198:849-851.
8. Otto M.W., Bruce S.E., Deckersbach T. Benzodiazepine use, cognitive impairment, and cognitive-behavioral therapy for anxiety disorders: issues in the treatment of a patient in need. Journal of Clinical Psychiatry 2005, 66(supplement 2):34-38.
9. Rosenbaum J.F. Attitudes toward benzodiazepines over the years. Journal of Clinical Psychiatry 2005, 66(supplement 2):4-8.
10. A receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annual Review of Pharmacology and Toxicology 2004, 44:475-498.
11. Sanger D.J. The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. CNS Drugs 2004, 18(supplement 1):9-15.
12. Schatzberg A.F., Cole J.O., DeBattista C. Manual of clinical psychopharmacology 2005, American Psychiatric Publishing, Washington, DC. 5th edn.
13. Soumerai S.B., Simoni-Wastila L., Singer C., et al. Lack of relationship between long-term use of benzodiazepines and escalation to high dosages. Psychiatric Services 2003, 54:1006-1011.
14. Stein D.J., Ipser J.C., Balkom A.J. Pharmacotherapy for social phobia. The Cochrane Library (Issue 4) 2004, Wiley, Chichester, (Cochrane Review).
15. Vermeeren A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 2004, 18:297-328.